Gallbladder & Digestive Health Panel
The Gallbladder & Digestive Health Panel evaluates key biomarkers associated with liver function, gallbladder activity, pancreatic enzymes, inflammation, and metabolic health. By combining the Comprehensive Metabolic Panel, GGT, lipase, amylase, CBC, CRP, and a lipid panel, this test provides a broad laboratory assessment of digestive system function and helps support clinical evaluation of symptoms that may involve the liver, pancreas, or biliary system.
- $635.46
- $134
- Save: 78.91%
The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.
Amylase
Also known as: C-Reactive Protein, CReactive Protein CRP, CRP
C-REACTIVE PROTEIN
Also known as: CBC, CBC includes Differential and Platelets, CBC/PLT w/DIFF, Complete Blood Count (includes Differential and Platelets)
NOTE: Ulta Lab Tests provides CBC test results from Quest Diagnostics as they are reported. Often, different biomarker results are made available at different time intervals. When reporting the results, Ulta Lab Tests denotes those biomarkers not yet reported as 'pending' for every biomarker the test might report. Only biomarkers Quest Diagnostics observes are incorporated and represented in the final CBC test results provided by Ulta Lab Tests.
Absolute Band Neutrophils (Only Reported If Detected)
Absolute Basophils
Absolute Blasts (Only Reported If Detected)
Absolute Eosinophils
Absolute Lymphocytes
Absolute Metamyelocytes (Only Reported If Detected)
Absolute Monocytes
Absolute Myelocytes (Only Reported If Detected)
Absolute Neutrophils
Absolute Nucleated Rbc (Only Reported If Detected)
Absolute Promyelocytes (Only Reported If Detected)
Band Neutrophils (Only Reported If Detected)
Basophils
Blasts (Only Reported If Detected)
Eosinophils
Hematocrit
Hemoglobin
Lymphocytes
MCH
MCHC
MCV
Metamyelocytes (Only Reported If Detected)
Monocytes
MPV
Myelocytes (Only Reported If Detected)
Neutrophils
Nucleated Rbc (Only Reported If Detected)
Platelet Count
Promyelocytes (Only Reported If Detected)
RDW
Reactive Lymphocytes (Only Reported If Detected)
Red Blood Cell Count
White Blood Cell Count
Also known as: Chem 12, Chemistry Panel, Chemistry Screen, CMP, Complete Metabolic Panel, Comprehensive Metabolic Panel CMP, SMA 12, SMA 20
Albumin
Albumin/Globulin Ratio
Alkaline Phosphatase
Alt
AST
Bilirubin, Total
Bun/Creatinine Ratio
Calcium
Carbon Dioxide
Chloride
Creatinine
Egfr African American
Egfr Non-Afr. American
GFR-AFRICAN AMERICAN
GFR-NON AFRICAN AMERICAN
Globulin
Glucose
Potassium
Protein, Total
Sodium
Urea Nitrogen (Bun)
Also known as: Gamma Glutamyl Transferase GGT, Gamma-Glutamyl Transferase, Gamma-Glutamyl Transpeptidase, Gamma-GT, GGTP, GTP
Ggt
Also known as: LPS
Lipase
Also known as: Cholesterol, HDL,Fasting Lipids,Cholesterol, LDL, Fasting Lipids, Lipid Panel (fasting), Lipid Profile (fasting), Lipids
Chol/HDLC Ratio
Cholesterol, Total
HDL Cholesterol
LDL-Cholesterol
Non HDL Cholesterol
Triglycerides
The Gallbladder & Digestive Health Panel panel contains 7 tests with 64 biomarkers .
Overview of the Gallbladder & Digestive Health Panel
The Gallbladder & Digestive Health Panel is a comprehensive laboratory assessment designed to evaluate key biomarkers associated with digestive system function, liver and gallbladder activity, pancreatic enzyme production, systemic inflammation, and metabolic health. By combining several widely used clinical tests into a single panel, it offers a broad view of physiological processes that influence digestion, nutrient metabolism, and abdominal organ health.
Digestive symptoms and metabolic changes can arise from many different underlying factors, including liver function abnormalities, gallbladder dysfunction, pancreatic enzyme imbalances, inflammatory processes, and metabolic disturbances. Because these systems are closely connected, evaluating multiple markers together can provide helpful insight into how the digestive system and related organs are functioning.
This panel includes the Comprehensive Metabolic Panel (CMP), Gamma-Glutamyl Transferase (GGT), Lipase, Amylase, Complete Blood Count (CBC) with Differential and Platelets, C-Reactive Protein (CRP), and a Lipid Panel. Together, these tests evaluate liver enzymes, bile-related markers, pancreatic enzymes, inflammatory indicators, blood cell health, and lipid metabolism.
The gallbladder plays an important role in digestion by storing and releasing bile produced by the liver, which helps break down dietary fats. Conditions affecting bile flow, liver health, pancreatic enzyme production, or systemic inflammation can sometimes influence digestive function. By assessing markers across these systems, this panel provides a comprehensive picture that may help healthcare providers investigate digestive symptoms, monitor metabolic health, or evaluate potential hepatobiliary and pancreatic concerns.
The Gallbladder & Digestive Health Panel is often used as part of a broader evaluation of digestive wellness and metabolic balance. The results may provide useful information about liver enzyme activity, pancreatic function, inflammatory status, and blood chemistry patterns that can influence digestion and overall gastrointestinal health.
When and Why Someone Would Order This Panel
Evaluating Digestive and Abdominal Symptoms
Healthcare providers may recommend the Gallbladder & Digestive Health Panel when patients experience symptoms that could involve the digestive organs. These symptoms may include abdominal discomfort, indigestion, nausea, bloating, changes in bowel habits, or difficulty digesting fatty foods. While symptoms alone cannot determine the underlying cause, laboratory markers can help identify patterns that may suggest involvement of the liver, gallbladder, pancreas, or inflammatory processes.
Gallbladder function is closely connected with bile production and flow. When bile flow becomes disrupted, it can sometimes lead to digestive discomfort or abnormal liver enzyme patterns. This panel includes multiple markers that help evaluate the liver and biliary system, providing useful information that may help guide further clinical evaluation.
Assessing Liver and Gallbladder Health
The liver and gallbladder work together to support digestion and metabolic balance. Liver enzymes measured in the Comprehensive Metabolic Panel and the additional GGT test can help identify changes associated with hepatobiliary stress or altered bile flow. Healthcare providers may use these markers to evaluate possible gallbladder involvement, bile duct issues, or general liver enzyme elevations.
Because gallbladder conditions such as gallstones or bile flow disturbances may affect liver enzyme patterns, testing multiple markers together can help provide a clearer picture of how these organs are functioning.
Investigating Pancreatic Enzyme Activity
The pancreas produces digestive enzymes that help break down fats, proteins, and carbohydrates. The enzymes lipase and amylase are commonly measured when healthcare providers want to evaluate pancreatic function. Elevated levels may sometimes be associated with pancreatic irritation or inflammation, which can contribute to abdominal pain or digestive symptoms.
Including these markers in the panel allows healthcare providers to assess whether pancreatic enzyme activity may be playing a role in digestive complaints.
Monitoring Inflammation and Metabolic Health
Digestive conditions may sometimes be associated with systemic inflammation or metabolic changes. The panel includes C-Reactive Protein (CRP), a marker of inflammation that may rise when inflammatory processes are present in the body. While CRP is not specific to digestive diseases, it can provide helpful context when interpreting digestive symptoms or metabolic patterns.
The inclusion of a Lipid Panel also provides insight into fat metabolism, which is closely linked to bile production and digestive health. Lipid abnormalities may influence gallbladder function or metabolic health, making them relevant to a broader digestive health evaluation.
Supporting Preventive Health Assessments
In some cases, healthcare providers may include digestive and metabolic markers as part of routine health evaluations or broader wellness assessments. Because digestive organs play an important role in nutrient metabolism and energy regulation, monitoring these markers may help identify trends or changes over time that could warrant further medical evaluation.
What Does the Panel Measure
Comprehensive Metabolic Panel (CMP)
The Comprehensive Metabolic Panel evaluates multiple biochemical markers related to liver function, kidney health, electrolyte balance, and glucose metabolism. Several markers within the CMP are particularly relevant to digestive and gallbladder health, including liver enzymes such as ALT (alanine aminotransferase), AST (aspartate aminotransferase), alkaline phosphatase, and bilirubin. These markers may provide insight into liver cell health, bile flow, and metabolic processes that influence digestion.
The CMP also measures glucose, electrolytes, and proteins such as albumin, which help assess overall metabolic balance and organ function.
Gamma-Glutamyl Transferase (GGT)
Gamma-Glutamyl Transferase (GGT) is an enzyme involved in glutathione metabolism and bile transport. It is often used as an additional marker of hepatobiliary activity and may help clarify the significance of elevated liver enzymes detected in the CMP. GGT levels can sometimes increase when bile flow is impaired or when the liver experiences certain metabolic stresses.
Pancreatic Enzymes: Lipase and Amylase
Lipase and amylase are digestive enzymes produced primarily by the pancreas. Lipase helps break down fats, while amylase contributes to carbohydrate digestion. Elevated levels of these enzymes may occur when the pancreas is inflamed or under stress. Measuring both enzymes can help healthcare providers evaluate pancreatic involvement in digestive symptoms.
Complete Blood Count with Differential and Platelets
The Complete Blood Count (CBC) with Differential and Platelets evaluates several components of blood health, including red blood cells, white blood cells, hemoglobin, hematocrit, and platelet levels. The differential portion provides a breakdown of different types of white blood cells, which can offer insight into immune activity and potential inflammatory responses.
Changes in blood cell counts may help healthcare providers identify patterns that could accompany infection, inflammation, or other physiological stresses.
C-Reactive Protein (CRP)
C-Reactive Protein is a marker of systemic inflammation produced by the liver. Elevated CRP levels may indicate inflammatory activity somewhere in the body. While CRP is not specific to digestive conditions, it can help provide context when evaluating symptoms that may involve inflammatory processes affecting digestive organs.
Lipid Panel
The Lipid Panel measures several markers related to fat metabolism, including total cholesterol, LDL cholesterol, HDL cholesterol, and triglycerides. Lipid metabolism is closely connected to bile production and fat digestion. Abnormal lipid levels may influence metabolic health and can sometimes be associated with conditions affecting the liver or gallbladder.
By combining these tests, the panel offers a multidimensional assessment of digestive physiology, hepatobiliary function, pancreatic enzyme activity, inflammation, and metabolic health.
How Patients and Healthcare Providers Use the Results
Identifying Patterns Across Digestive Organs
The Gallbladder & Digestive Health Panel provides healthcare providers with a set of laboratory markers that can be interpreted together to evaluate digestive organ function. Because the liver, gallbladder, pancreas, and metabolic systems interact closely, examining several biomarkers at once can help reveal patterns that might not be apparent when tests are performed individually.
For example, elevations in certain liver enzymes combined with changes in GGT may suggest hepatobiliary involvement, while elevated lipase or amylase may indicate pancreatic enzyme activity changes. These patterns may help healthcare providers determine whether additional diagnostic testing or imaging studies should be considered.
Supporting Evaluation of Gallbladder and Biliary Conditions
Gallbladder conditions often involve disruptions in bile flow or inflammation within the hepatobiliary system. Laboratory markers such as alkaline phosphatase, bilirubin, and GGT may sometimes change when bile ducts or gallbladder function are affected. These markers can help healthcare providers assess whether gallbladder-related issues may be contributing to digestive symptoms.
Conditions that may be evaluated in the context of these laboratory markers include gallstones, biliary obstruction, or gallbladder inflammation, though additional imaging studies are typically required for diagnosis.
Assessing Pancreatic Health
Pancreatic enzymes measured in this panel may help healthcare providers evaluate pancreatic involvement in abdominal pain or digestive symptoms. Elevated lipase or amylase levels may sometimes be associated with pancreatic inflammation or pancreatic enzyme disturbances, which can affect digestion and nutrient breakdown.
When pancreatic markers are elevated, healthcare providers may consider additional diagnostic testing or imaging to further evaluate pancreatic function.
Monitoring Inflammatory and Metabolic Health
The inclusion of CRP and lipid markers allows healthcare providers to evaluate systemic inflammation and metabolic patterns that may influence digestive health. Chronic inflammation and lipid metabolism abnormalities may sometimes contribute to metabolic conditions or digestive disturbances.
These markers may also be used over time to monitor changes related to lifestyle factors, dietary adjustments, or medical management strategies.
Guiding Further Medical Evaluation
Laboratory results from this panel are typically interpreted in combination with clinical history, physical examination, and other diagnostic tests. Abnormal results may help healthcare providers determine whether additional evaluations—such as imaging studies, specialized laboratory testing, or referrals to specialists—may be appropriate.
Because digestive symptoms can arise from many different causes, laboratory markers provide an important starting point for understanding potential physiological changes that may be affecting digestive health.
A Comprehensive Approach to Digestive Health Assessment
Digestive health depends on the coordinated function of several organs, including the liver, gallbladder, pancreas, and gastrointestinal system. When these organs are functioning properly, they work together to support nutrient digestion, metabolic balance, and overall physiological wellness. When disruptions occur, laboratory markers can provide valuable insight into the biological processes involved.
The Gallbladder & Digestive Health Panel offers a comprehensive laboratory evaluation that examines multiple aspects of digestive physiology. By assessing liver enzymes, pancreatic enzymes, inflammatory markers, blood cell health, and lipid metabolism, the panel provides a broad overview of the biological systems that influence digestion and metabolic health.
This combination of tests allows healthcare providers to evaluate patterns that may suggest hepatobiliary activity, pancreatic enzyme changes, metabolic imbalances, or inflammatory responses. Because digestive symptoms can have many possible causes, examining a range of biomarkers helps create a more complete picture of how the body’s digestive and metabolic systems are functioning.
For patients and healthcare providers alike, laboratory testing can serve as an important tool in understanding digestive health. While laboratory results alone do not diagnose medical conditions, they can help guide further evaluation and support informed discussions about digestive wellness and metabolic health.
By providing a comprehensive set of clinically relevant markers, the Gallbladder & Digestive Health Panel supports a deeper understanding of the biological processes involved in digestion and offers a valuable foundation for further clinical assessment when needed.